The challenges of an HIV vaccine enterprise (multiple letters) Journal Article


Authors: Zinkernagel, R. M.; Wolf, H.; Klasner, R. D.; Fauci, A. S.; Corey, L.; Nabel, G. J.; Gayle, H.; Berkley, S.; Haynes, B. F.; Baltimore, D.; Collins, C.; Douglas, R. G.; Esparza, J.; Francis, D. P.; Ganguly, N. K.; Gerberding, J. L.; Johnson, M. I.; Kazatchkine, M. D.; McMichael, A. J.; Makgoba, M. W.; Pantaleo, G.; Piot, P.; Shao, Y.; Tramont, E.; Varmus, H.; Wasserheit, J. N.
Article Title: The challenges of an HIV vaccine enterprise (multiple letters)
Keywords: disease course; human immunodeficiency virus infection; letter; drug research; cellular immunity; human immunodeficiency virus; vaccine production; health care planning; policy; drug industry; neutralizing antibody; biomedicine; human immunodeficiency virus vaccine; human; priority journal
Journal Title: Science
Volume: 303
Issue: 5662
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2004-02-27
Start Page: 1294
End Page: 1297
Language: English
DOI: 10.1126/science.303.5662.1294
PROVIDER: scopus
DOI/URL:
Notes: Cited By (since 1996):6 -- Export Date: 16 June 2014 -- CODEN: SCIEA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Harold Varmus
    96 Varmus